Correlation Between PDS Biotechnology and Geron

Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Geron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Geron into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PDS Biotechnology Corp and Geron, you can compare the effects of market volatilities on PDS Biotechnology and Geron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Geron. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Geron.

Diversification Opportunities for PDS Biotechnology and Geron

0.84

Correlation Coefficient

PDS Biotechnology  Geron

Very poor diversification

The 3 months correlation between PDS and Geron is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Geron in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Geron and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Geron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Geron has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Geron go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Geron

Given the investment horizon of 90 days PDS Biotechnology Corp is expected to generate 1.17 times more return on investment than Geron. However, PDS Biotechnology is 1.17 times more volatile than Geron. It trades about -0.06 of its potential returns per unit of risk. Geron is currently generating about -0.18 per unit of risk. If you would invest  171.00  in PDS Biotechnology Corp on December 27, 2024 and sell it today you would lose (47.00) from holding PDS Biotechnology Corp or give up 27.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	98.36%
Values	Daily Returns

PDS Biotechnology Corp  vs.  Geron

PDS Biotechnology Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Geron

Risk-Adjusted Performance

Very Weak

Over the last 90 days Geron has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with PDS Biotechnology and Geron

The main advantage of trading using opposite PDS Biotechnology and Geron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Geron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Geron will offset losses from the drop in Geron's long position.

The idea behind PDS Biotechnology Corp and Geron pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.